...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation
【24h】

GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation

机译:GPRASP蛋白是造血干细胞移植的关键负调节因子

获取原文
获取原文并翻译 | 示例

摘要

Hematopoietic stem cell (HSC) transplantation (HSCT) is often exploited to treat hematologic disease. Donor HSCs must survive, proliferate, and differentiate in the damaged environment of the reconstituting niche. Illuminating molecular mechanisms regulating the activity of transplanted HSCs will inform efforts to improve HSCT. Here, we report that G-protein-coupled receptor-associated sorting proteins (GPRASPs) function as negative regulators of HSCT. Silencing of Gprasp1 or Gprasp2 increased the survival, quiescence, migration, niche retention, and hematopoietic repopulating activity of hematopoietic stem and progenitor cells (HSPCs) post-transplant. We further show that GPRASP1 and GPRASP2 promote the degradation of CXCR4, a master regulator of HSC function during transplantation. CXCR4 accumulates in Gprasp-deficient HSPCs, boosting their function posttransplant. Thus, GPRASPs negatively regulate CXCR4 stability in HSCs. Our work reveals GPRASP proteins as negative regulators of HSCT and CXCR4 activity. Disruption of GPRASP/CXCR4 interactions could be exploited in the future to enhance the efficiency of HSCT.
机译:造血干细胞(HSC)移植(HSCT)通常被利用以治疗血液病疾病。供体HSC必须存活,增殖和区分重构利基的受损环境。调节移植HSCs活性的照明分子机制将努力改善HSCT。这里,我们将G蛋白偶联的受体相关分选蛋白(GPRASPS)函数作为HSCT的负调节剂作用。 GPRASP1或GPRASP2的沉默增加了移植后造血干细胞和祖细胞(HSPCS)的存活率,静脉,迁移,乳房保留和造血重新流动活性。我们进一步表明,GPRASP1和GPRASP2在移植过程中促进了CXCR4,HSC功能的母稳压器的降解。 CXCR4累积在GPRASP缺陷的HSPC中,促进其功能后普及。因此,GPRASPS负调节HSC中的CXCR4稳定性。我们的作品揭示了GPRASP蛋白作为HSCT和CXCR4活性的负调节因子。可以在将来利用GPRASP / CXCR4互动的破坏,以提高HSCT的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号